side effects of glp 1 drugs A monthly GLP-1 dose could cut the number shots patients take each year from 52 to 12. from the drug — mainly gastrointestinal symptoms — were similar to or Part 2 of a 3-Part
Description
Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
We always suggest that qualified patients try to get insurance coverage for weight loss medication before pursuing compounded semaglutide
The physiological roles of GLP-1 are more than sufficient for it to be targeted for the development of anti-diabetic and anti-obesity medication [2]
Available at: 22 RanganathLRBeetyJMMorganLMWrightJWHowlandRMarksV
Lancet (2022) 400(10366):186981
